Diaceutics Plc

Diaceutics (DXRX)

Buy
Sell
Company name:Diaceutics Plc
EPIC:DXRXTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BJQTGV64
Market Segment:ASQ1Share Type:DE
WWW Address:www.diaceutics.comDescription:ORD GBP0.002
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 134.50 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 132.00 137.00 134.50 138.50 134.50 1,792
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 113.07 84.07 -0.05 0.62 - 216.94 - 191.00 - 93.50

Diaceutics Key Figures

(at previous day's close)
Market Cap.113.07m
Shares In Issue84.07m
Prev. Close134.50
PE Ratio216.94 
Dividend Yield-%
EPS - basic0.62p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-0.75p
Return On Equity (ROE)1.98%
Operating Margin3.70%
PEG Factor- 
EPS Growth Rate-%
Dividends PS Growth Rate-%
Net Debt-9.48m
Gross Gearing10.01%
Quick Assets18.48m
Net Working Capital16.24m
Intangibles / Fixed Assets96.57%
Turnover PS15.99p
Pre-Tax Profit PS0.59p
Retained Profit PS0.47p
Cash PS13.94p
Net Cash PS11.28p
Net Tangible Asset Value PS *19.47p
Net Asset Value PS23.95p
Spread5.00 (3.65%) 

Diaceutics Balance Sheet

DXRX:Liabilities+EQDXRX:Assets

Share Price Performance

Sample Period HighLow
1 week138.50134.50
4 weeks140.50134.50
12 weeks162.50108.00
1 year191.0093.50

Share Price Chart (5 years)

Diaceutics Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week137.00-2.50-1.82134.500.01135.67
4 weeks137.50-3.00-2.18134.500.04137.73
12 weeks162.50-28.00-17.23108.000.04126.33
26 weeks151.50-17.00-11.22108.000.07146.45
1 year94.5040.0042.3393.500.05142.24
3 years84.5050.0059.1778.000.04130.85
5 years84.5050.0059.1778.000.04130.85

Diaceutics Key Management Ratios

Diaceutics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio216.94 
Tobin's Q Ratio 5.05 
Tobin's Q Ratio (excl. intangibles)6.08 
Dividend Yield-%
Market-to-Book Ratio5.62 
Price-to-Pre-Tax Profit PS227.36 
Price-to-Retained Profit PS284.19 
Price-to-Cash Flow PS-179.57 
Price-to-Sales PS8.41 
Price-to-Net Tangible Asset Value PS6.91 
Price-to-Cash PS9.65 
Net Working Capital PS19.31 
Price Pct to Working Capital PS6.96%
Earnings Yield0.46%
Average PE164.52 
Years in average1 
PE to PE average131.86%

Diaceutics Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-42.38%
Net Gearing (excl. Intangibles)-50.95%
Gross Gearing10.01%
Gross Gearing (excl. Intangibles)12.03%
Gearing Under 1 Year10.01%
Gearing Under 1 Year (excl. Intgbl)12.03%
Assets/Equity1.11 
Cash/Equity58.22 
(Liquidity Ratios)
Net Working Capital to Total Assets72.58%
Current Ratio8.25 
Quick Ratio (Acid Test)8.25 
Liquidity Ratio5.23 
Cash & Equiv/Current Assets63.43%
(Solvency Ratios)
Enterprise Value101.35m
CFO/Sales-0.05 
CFO/Attributable Profit- 
CFO/Assets-0.03 
CFO/Debt-0.28 
Total Debt/Equity Market Value0.02 
Total Debt/Sales0.17 
Total Debt/Pre-Tax Profit4.50 
Total Debt2.24m
Total Debt/Net Current Assets0.14%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs- 
Beta (60-Mnth)Beta (36-Mnth)
-0.0476-0.0476

Diaceutics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)2.47%
Return On Assets (ROA)1.78%
Net Profit Margin2.96%
Assets Turnover0.60 
Return On Equity (ROE)1.98%
Return On Investment (ROI)1.98%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio1.98%
Net Income Of Revenues2.96%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.67 
Fixed Assets Turnover3.45 
Current Assets Turnover0.73 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales1.66 
Debtors-to-Sales50.26%
Debt Collection Period183.46Days

Diaceutics Dividends

Sorry No Data Available

Diaceutics Fundamentals

 31 Dec 2019 (GBP)
turnover13.44100.00%m
pre tax profit0.503.70%m
attributable profit0.402.96%m
retained profit0.402.96%m
eps - basic (p)0.62 
eps - diluted (p)0.62 
dividends per share- 

Diaceutics Balance Sheet

 31 Dec 2019 (GBP)
DXRX:Liabilities+EQDXRX:Assets
 31 Dec 2019 (GBP)
ASSETS
fixed assets fixed assets0.130.60%m
intangibles intangibles3.7616.81%m
fixed investments fixed investments--%m
current assets - other current assets - other--%m
stocks stocks--%m
debtors debtors6.7630.20%m
cash & securities cash & securities11.7252.39%m
TOTAL22.37100%m
LIABILITIES
creditors - short creditors - short2.2410.01%m
creditors - long creditors - long--%m
creditors - other creditors - other--%m
subordinated loans subordinated loans--%m
insurance funds insurance funds--%m
TOTAL2.2410.01%m
EQUITY
ord cap, reserves ord cap, reserves20.1389.99%m
prefs, minorities prefs, minorities--%m
TOTAL20.1389.99%m
OTHER
NAV Basic- 
NAV Diluted- 

Diaceutics Cash Flow Statement

31 Dec 2019 (GBP)
Operating CF-0.63m
Pre-Financing CF-3.55m
Retained CF9.74m

Diaceutics Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
LSE
DXRX
Diaceutics
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201201 02:08:06